192 related articles for article (PubMed ID: 20563534)
1. Therapeutic antibodies for the treatment of pancreatic cancer.
Chames P; Kerfelec B; Baty D
ScientificWorldJournal; 2010 Jun; 10():1107-20. PubMed ID: 20563534
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Amedei A; Niccolai E; Prisco D
Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
[TBL] [Abstract][Full Text] [Related]
3. Future strategies for targeted therapies and tailored patient management in pancreatic cancer.
Ko AH
Semin Oncol; 2007 Aug; 34(4):354-64. PubMed ID: 17674964
[TBL] [Abstract][Full Text] [Related]
4. Novel targets for pancreatic cancer therapy.
Philip PA
Surg Oncol Clin N Am; 2010 Apr; 19(2):419-29. PubMed ID: 20159523
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for pancreatic cancer: A long and hopeful journey.
Xu JW; Wang L; Cheng YG; Zhang GY; Hu SY; Zhou B; Zhan HX
Cancer Lett; 2018 Jul; 425():143-151. PubMed ID: 29605510
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy of pancreatic cancer using monoclonal antibodies and immune response modifiers.
Friess H; Gassmann M; Büchler MW
Int J Pancreatol; 1997 Feb; 21(1):43-52. PubMed ID: 9127173
[TBL] [Abstract][Full Text] [Related]
7. Combinational therapy: new hope for pancreatic cancer?
Shi S; Yao W; Xu J; Long J; Liu C; Yu X
Cancer Lett; 2012 Apr; 317(2):127-35. PubMed ID: 22138436
[TBL] [Abstract][Full Text] [Related]
8. Advanced stage pancreatic cancer: novel therapeutic options.
Saif MW
Expert Rev Clin Pharmacol; 2014 Jul; 7(4):487-98. PubMed ID: 24939470
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody therapies targeting pancreatic ductal adenocarcinoma.
Engelhardt K; Riley C; Cooke L; Mahadevan D
Curr Drug Discov Technol; 2006 Dec; 3(4):231-43. PubMed ID: 17430101
[TBL] [Abstract][Full Text] [Related]
10. The Hepatobiliary and Pancreatic Oncology (HBPO) Group of the Japan Clinical Oncology Group (JCOG): history and future direction.
Furuse J; Ishii H; Okusaka T
Jpn J Clin Oncol; 2013 Jan; 43(1):2-7. PubMed ID: 23100604
[TBL] [Abstract][Full Text] [Related]
11. Molecular therapy in pancreatic adenocarcinoma.
MacKenzie MJ
Lancet Oncol; 2004 Sep; 5(9):541-9. PubMed ID: 15337483
[TBL] [Abstract][Full Text] [Related]
12. Emerging antibodies for the treatment of pancreatic cancer.
Andrikou K; Peterle C; Pipitone S; Salati M; Cascinu S
Expert Opin Emerg Drugs; 2017 Mar; 22(1):39-51. PubMed ID: 28253833
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer: from molecular pathogenesis to targeted therapy.
Strimpakos A; Saif MW; Syrigos KN
Cancer Metastasis Rev; 2008 Sep; 27(3):495-522. PubMed ID: 18427734
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer.
Desai NV; Sliesoraitis S; Hughes SJ; Trevino JG; Zlotecki RA; Ivey AM; George TJ
Cancer Med; 2015 Aug; 4(8):1224-39. PubMed ID: 25766842
[TBL] [Abstract][Full Text] [Related]
15. Molecular-targeted agents in pancreatic cancer.
Saad ED; Hoff PM
Cancer Control; 2004; 11(1):32-8. PubMed ID: 14749621
[TBL] [Abstract][Full Text] [Related]
16. Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer.
de Gramont A; Van Cutsem E
Oncology; 2005; 69 Suppl 3():46-56. PubMed ID: 16301835
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic neoplasm in 2011: an update.
Saif MW
JOP; 2011 Jul; 12(4):316-21. PubMed ID: 21737886
[TBL] [Abstract][Full Text] [Related]
18. Current approaches to novel therapeutics in pancreatic cancer.
Akerele CE; Rybalova I; Kaufman HL; Mani S
Invest New Drugs; 2003 Feb; 21(1):113-29. PubMed ID: 12795537
[TBL] [Abstract][Full Text] [Related]
19. Approaches to localized pancreatic cancer.
Loos M; Kleeff J; Friess H; Büchler MW
Curr Oncol Rep; 2008 May; 10(3):212-9. PubMed ID: 18765151
[TBL] [Abstract][Full Text] [Related]
20. Molecular targeted therapies for pancreatic cancer.
Borja-Cacho D; Jensen EH; Saluja AK; Buchsbaum DJ; Vickers SM
Am J Surg; 2008 Sep; 196(3):430-41. PubMed ID: 18718222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
